LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services. The Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. The Community-Based Services segment offers a range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand services to patients in their home or in a medical facility. The Facility-Based Services segment serves patients suffering from respiratory failure, neuromuscular disorders, cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments. The company also operates institutional pharmacy, a family health center, a rural health clinic, and a retail pharmacy, as well as offers physical therapy services. As of December 31, 2017, it operated 318 home health services locations, 91 hospice locations, 12 community-based service locations, and 11 long-term acute care hospitals with 15 locations. LHC Group, Inc. was founded in 1994 and is based in Lafayette, Louisiana.
Industry, Sector and Symbol
Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
SymbolNASDAQ:LHCG
CUSIP50187A10
Phone337-233-1307
Debt
Debt-to-Equity Ratio0.24
Current Ratio1.65
Quick Ratio1.65
Price-To-Earnings
Trailing P/E Ratio35.71
Forward P/E Ratio24.69
P/E Growth1.37
Sales & Book Value
Annual Sales$1.07 billion
Price / Sales1.47
Cash Flow$3.1992 per share
Price / Cash27.01
Book Value$28.54 per share
Price / Book3.03
Profitability
EPS (Most Recent Fiscal Year)$2.42
Net Income$50.11 million
Net Margins4.07%
Return on Equity9.29%
Return on Assets5.97%
Miscellaneous
Employees14,554
Outstanding Shares18,280,000
